Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Feb 21, 2014

30339_dirs_2014-02-21_6db979f2-555d-4e5a-afbb-b0349908dc4d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-02-19

Reporting Person: Malone Daniel (Vice President & Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-19 Common Stock F 87.0000 $47.7400 Disposed 14215.3252 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7.7578 Indirect
Common Stock 4176.5814 Indirect